Expressions of KLF2 and chemokine receptor CCR7 in pulmonary adenocarcinoma.
Meiji Itakura(Chiba Cancer Center), Toshihiko Iizasa(Chiba Cancer Center), Masato Shingoji(Chiba Cancer Center)
Cited by 0
Related Papers
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
|Lung Cancer|2013|261
Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease
|The Journal of Experimental Medicine|2000|198
Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations
|International Journal of Clinical Oncology|2014|167
Comparison of 21‐gauge and 22‐gauge aspiration needle during endobronchial ultrasound‐guided transbronchial needle aspiration
|Respirology|2010|141
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
|Nature Communications|2020|107